Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-10

FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for a generic Bupropion Hydrochloride Extended-Release (XL) product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)